Fig. 3From: Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphomaDVH for (a) HT, (b) VMAT, (c) IMRT and (d) 3D-CRTplans for the same patientBack to article page